Home > Income Statement > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Revenue

    Back to Income Statement
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹286 Cr₹282 Cr₹311 Cr₹222 Cr₹179 Cr

What is the latest Revenue of SAMRAT PHARMACHEM ?

The latest Revenue ratio of SAMRAT PHARMACHEM is ₹286 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹286 Cr
Mar2024₹282 Cr
Mar2023₹311 Cr
Mar2022₹222 Cr
Mar2021₹179 Cr

How is Revenue of SAMRAT PHARMACHEM Trending?

Years Revenue % Change
Mar2025 ₹286 Cr
1.52
Mar2024 ₹282 Cr
-9.36
Mar2023 ₹311 Cr
40.09
Mar2022 ₹222 Cr
23.87
Mar2021 ₹179 Cr -

Compare Revenue of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹70.7 Cr 11.1% 2.8% -37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

11.1%

2.8%

-37%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses